Tag: GMP compliance

Legacy Equipment Risk Matrix Template (Downloadable)

Legacy Equipment Risk Matrix Template (Downloadable) Legacy Equipment Risk Matrix Template (Downloadable) In the context of the pharmaceutical validation lifecycle, ensuring the integrity and compliance of legacy equipment is vital for maintaining product quality and regulatory approval. This article provides…

Establishing Proven Acceptable Ranges Through Robustness Testing

Establishing Proven Acceptable Ranges Through Robustness Testing Establishing Proven Acceptable Ranges Through Robustness Testing Robustness testing is a critical aspect of process validation in the pharmaceutical industry. It supports the establishment of Proven Acceptable Ranges (PARs) necessary for the process…

Linking Legacy Equipment to Current SOPs and Workflows

Linking Legacy Equipment to Current SOPs and Workflows Linking Legacy Equipment to Current SOPs and Workflows In the evolving landscape of pharmaceutical manufacturing, maintaining compliance while utilizing legacy equipment presents unique challenges. This article serves as a practical guide for…

Inter- and Intra-batch Variability: A Risk to Process Robustness

Inter- and Intra-batch Variability: A Risk to Process Robustness Inter- and Intra-batch Variability: A Risk to Process Robustness Ensuring robust pharmaceutical processes is paramount for maintaining product quality and meeting regulatory standards. The presence of inter- and intra-batch variability poses…

Equipment Lifecycle Management: Adding Legacy Equipment

Equipment Lifecycle Management: Adding Legacy Equipment Equipment Lifecycle Management: Adding Legacy Equipment Step 1: User Requirement Specification (URS) & Risk Assessment In the pharmaceutical industry, developing a User Requirement Specification (URS) is the foundational step for successful validation activities. The…

Robustness Studies for Critical Quality Attributes (CQAs)

Robustness Studies for Critical Quality Attributes (CQAs) Robustness Studies for Critical Quality Attributes (CQAs) Robustness studies are vital for establishing and ensuring the pharmaceutical quality of a product. Central to this process is understanding Critical Quality Attributes (CQAs) and their…

How to Define Criticality for Legacy Equipment

How to Define Criticality for Legacy Equipment How to Define Criticality for Legacy Equipment In today’s highly regulated pharmaceutical landscape, defining the criticality of legacy equipment is essential for maintaining compliance with FDA, EMA, and other regulatory requirements. This tutorial…

How to Evaluate Edge of Failure and Normal Operating Ranges

How to Evaluate Edge of Failure and Normal Operating Ranges How to Evaluate Edge of Failure and Normal Operating Ranges The evaluation of the edge of failure and normal operating ranges is critical in ensuring that pharmaceutical processes remain within…

Handling Non-Compliant Legacy Equipment: Mitigation Plans

Handling Non-Compliant Legacy Equipment: Mitigation Plans Handling Non-Compliant Legacy Equipment: Mitigation Plans Step 1: Understanding User Requirements Specification (URS) & Risk Assessment The initial stage in the pharmaceutical validation lifecycle involves developing a User Requirements Specification (URS) and conducting a…

Identifying and Controlling Sources of Process Variability

Identifying and Controlling Sources of Process Variability Identifying and Controlling Sources of Process Variability In the highly regulated pharmaceutical environment, ensuring process robustness is critical for compliance and product quality. This comprehensive guide outlines a step-by-step validation process that adheres…